Physician

Andrew Wayne Beharrie, M.D.

According to 2025 Medicare claims, Andrew Beharrie, M.D. (NPI: 1952361982) practices sports medicine in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 07410-2820. Beharrie is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Beharrie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 383 traditional Medicare patients, billed 3,538 HCPCS/CPT codes, and received $171,786 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 406 prescription claims across 175 beneficiaries totaling $2,936 in drug costs, led by Cyclobenzaprine Hcl (Cyclobenzaprine Hcl). 2023 DME data shows 47 claims. Open Payments data shows 11 records totaling $481. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $15,534 to $2,936. For DME billing, reported payments moved sharply higher in recent years, from $1,214 to $4,858.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	668	10,842	$234,121
2016	681	9,107	$206,179
2017	580	8,582	$197,781
2018	313	4,067	$86,609
2019	107	629	$43,448
2020	154	867	$69,135
2021	230	1,504	$108,521
2022	273	2,192	$130,934
2023	340	3,047	$153,558
2024	383	3,538	$171,786

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	184	355	$15,534
2016	150	271	$16,146
2017	153	293	$4,892
2018	100	176	$4,979
2019	47	87	$622
2020	68	128	$810
2021	103	217	$1,996
2022	127	265	$2,467
2023	154	351	$3,043
2024	175	406	$2,936

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	30	45	$12,905
2016	N/R	17	$331
2017	25	47	$12,775
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	42	$2,412
2023	N/R	47	$3,216
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	118	119	$136
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	113	139	$107
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	168	286	$72
20610	Aspiration and/or injection of fluid from large joint	159	269	$60
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	142	1,676	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	38	1,079	$1,096
Meloxicam	Meloxicam	174	5,340	$436
Methylprednisolone	Methylprednisolone	66	414	$434
Celecoxib	Celecoxib	21	630	$376
Gabapentin	Gabapentin	21	582	$175

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$481	Stratus Medical, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Wayne Beharrie, M.D.?

Tedicare shows public-source Medicare data for Andrew Wayne Beharrie, M.D. (NPI 1952361982), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Wayne Beharrie, M.D. have ACO affiliation data?

Andrew Wayne Beharrie, M.D. is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Andrew Wayne Beharrie, M.D.?

Andrew Wayne Beharrie, M.D. is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Andrew Wayne Beharrie, M.D. have Open Payments data?

Andrew Wayne Beharrie, M.D. has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.